- Home
- / Werewolf Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Werewolf Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.7
2024-10-29
Market Capitalization
$118.9 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 14.8M | 18.7M | 18.7M | 19.0M | 15.8M |
| Operating expense total | 72.5M | 75.5M | 60.7M | ||
| EBIT | (50.1M) | (56.1M) | (40.5M) | (73.6M) | (60.7M) |
| Investment income | 104.0K | 1.9M | |||
| Interest income | 7.4M | 6.7M | 3.1M | ||
| Interest expense | 3.1M | 3.3M | |||
| Net Income | (50.0M) | (53.8M) | (37.4M) | (70.5M) | (60.8M) |
| EPS | (1.9) | (1.0) | (1.6) | (1.3) |